Market Research Blog – Page 11166 – New Product Development

Angiography Devices Market is expected to reach a valuation of US$ 12,116.7 Million in 2022

[297 Pages Report] In 2022, the global angiography devices market is expected to be worth $12,116.7 million. The expanding scope of application and technological innovation are expected to be the primary growth drivers in the market. Overall angiography device sales are expected to grow at a 6.2% CAGR between 2022 and 2032, totaling around US$ 22,112 million by the end of 2032.

Angiography is an imaging procedure which provides visualization of blood vessel to detect narrow, blocked, enlarged arteries or veins in the body. Local or general anesthesia has been given to the patient during angiography procedure. This procedure uses various imaging technologies such as, Magnetic Resonance Imaging, Computed Tomography, X-ray and others. The superior quality of angiography imaging over conventional techniques is increasing the adoption of angiography devices especially for heart related disorders.

The MRI and CT angiography devices would be the most prominent products in this market owing to its efficacy, minimal side effects and short duration in terms of outcome. Commercialization of high end imaging technologies and increasing affordability of patients has increases the scope of hybrid angiography devices, in developed region. The demand for angiography devices in developing region would get reduced owing to its relatively saturated market situation. This market would be further driven by replacement of old devices.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1186

Angiography Devices Market: Overview

By device, the angiography device market was dominated by more advanced technologies such as MRI and CT, owing to their high efficiency over conventional technologies. Recently launched, Real-time 3D echocardiography by Siemens Healthcare is one of the key development in angiography devices market, which is used to diagnose various heart and coronary conditions. By procedure, coronary angiography and pulmonary angiography are the dominating procedure, owing to its high prevalence. By end-users, hospitals and surgical centers hold promising share, followed by diagnostic centers. This is due to premium pricing of angiography devices, which is unaffordable for the medium scale diagnostic centers. By disease indication, Coronary Artery Disease (CAD) is the leading segment due to its high incidence and absence of alternative diagnostic technique.

Angiography Devices Market: Drivers and Restraints

Increasing CVD incidences, growing number of geriatric population, dysfunctional lifestyle, growing demand for sophistication diagnostic procedures are driving the growth of angiography devices market, globally. Also, the rising awareness for cardiovascular disease diagnosis and treatment, favorable government regulation to commercialize angiography devices are the additional factors fueling the growth of angiography devices market. However, the high cost angiography devices, lack of reimbursement, and unaffordability across emerging economies are some of the factors impeding the market growth. However, the companies operating in this market are actively focusing on the commercialization of low cost system to grab the highest market share in emerging economies.

Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-1186

Angiography Devices Market: Segmentation

The global angiography devices market is segmented based on, device, product type, application, procedures, end use and indication.

Based on devices, the global angiography devices market is segmented into the following:

Magnetic Resonance Angiography (MRA)

Computed Tomography Angiography (CTA)

Conventional Angiography

Digital Subtraction Angiography (DSA)

Catheter angiography

Coronary angiography

Others

Based on procedure, the global angiography devices market is segmented into the following:

Coronary Angiography

Pulmonary Angiography

Cerebral Angiography

Extremity Angiography

Renal Angiography

Based on end users, the global angiography devices market is segmented into the following:

Hospitals and Surgical Centers

Diagnostics Centers

Academic and Research Institutes

Based on indication, the global angiography devices market is segmented into the following:

Coronary Artery Disease (CAD)

Congenital Heart Disease

Congestive Heart Failure

Kidney Disorders

Others

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1186

Angiography Devices Market: Region-wise Outlook

North America was the lading region for angiography devices in terms of revenue in 2015, followed by Europe. Increasing incidence of coronary disorder owing to dysfunction lifestyle is the prime factor driving the growth of angiography device market in these region. However, the similar kind of trend is now shifting towards emerging economies which is expected to create notable growth opportunity for the angiography device during the forecast period.

Angiography Devices Market: Key Players

Leading players operating in angiography devices includes, Shimadzu Corporation, Royal Philips Electronics, Siemens Healthcare, GE Healthcare, Toshiba Medical System Corporation, Shimadzu Corporation, St. Jude Medical, Inc., Toshiba Medical Systems Corporation, Cordis Corporation, Medtronic, Inc., and Abbott Vascular (Abbott Laboratories). Companies operating in this market are seeking for novel product to gain core competencies in the market. These companies are also conducting collaborative studies with the clinical research institutes to sustain their market position.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Multiple Unit Pellet Systems Market expanding at a CAGR of 3.5% to reach an ~US$ 5.07 Bn by the end of 2032

[349 Pages Report] As per Future Market Insights, the global multiple unit pellet systems (MUPS) market valued US$ 3.48 Bn in 2021 and is projected to exhibit growth at 3.5% CAGR between 2022 and 2032, with an estimated valuation of US$ 5.07 Bn in 2032.

MUPS are multi-particulate pellet formulations that complement the advantages of pellet-filled capsules and tablets into a single dosage form. Once administered as tablets, MUPS disintegrate into their subunits rapidly after swallowing and starts diffusing their subunits across the stomach and small intestine.

When compared to simple tablets or capsules, MUPS systems have advantages, such as better dose adjustment and a reduction in intestinal mucosa irritation with simple units’ drug disintegration. The multiparticulate technology makes it feasible to administer drugs that really are incompatible. These dosage forms are gaining transactions during the anticipated period due to their high patient compliance.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15446

Prolonged or delayed-release MUPS formulations provide drugs at a pre- determined rate, extending the therapeutic effect, in contrast to the traditional delivery systems. Furthermore, intestinal systems for drug delivery may depend on delayed release of multi-particulate formulations to reduce dose dumping and decrease dosage variability between individuals.

Key Takeaways from Market Study

Extended-release dosage forms are the leading segment as a formulation, and held approximately 47.1% of value share in 2021.
Based on dosage form, capsules are leading in the global multiple unit pellet systems market, and is expected to exhibit growth at a CAGR rate of 3.3% through 2022 & beyond.
By drug class, the proton pump inhibitors segment is expected to witness growth at 3.6% CAGR during the forecast period.
Hospital pharmacies are projected to hold around 31.4% of the demand share by 2032.
North America is expected to dominate the global MUPS market, with the U.S. accounting for significant share in the market.

“Increasing demand for gastro retentive drug delivery systems and rapid rise in demand for modified release MUPS products, is set to propel the demand of multiple unit pellet systems across the globe,” says an analyst of future market insights.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15446

Market Competition

Leading companies in the market for MUPS are implementing a variety of key category, such as new launches, mergers and acquisitions, partnerships, and collaborations, to boost their market presence and expand their existing product portfolio.

For instance, the Proton pump inhibitor incorporating delayed-release Mini Capsule, 20 mg OTC received official approval from the USFDA in May 2022 for Perrigo Company plc. The medication will be sold under store brand names that resemble Prilosec OTC from the pharmacy.
Mannogem XL Opal, Mannogem XL Ruby, Mannogem Emerald, and Mannogem Onyx were added to SPI Pharma’s line of Mannogem Mannitol products in March 2020 for use in a variety of patient-friendly oral dosage forms. With the aid of Mannogem XL Opal and Ruby, manufacturers may effectively produce complex dosage forms, such as MUPS and controlled-release ODTs.

Key Players:

AstraZeneca plc
Merck KGaA
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Galderma SA
Novartis AG
GlaxoSmithKline Plc
Perrigo Company Plc.
Cipla Ltd.
Astellas Pharma Inc.
Takeda Pharmaceutical Company Ltd.
Eli Lilly and Company
Dr. Reddy’s Laboratories Ltd.
Endo International Inc.
Mylan Pharmaceuticals Inc.
Teva Pharmaceuticals Ltd.
AbbVie (Allergan)
GlaxoSmithKline Plc
Bayer AG

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Multiple Unit Pellet Systems Market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the formulation (extended-release dosage form, delayed release dosage form, delayed release orodispersible dosage form), dosage form (tablets, capsules, sachets), drug class (anti-hypertensives, proton pump inhibitors, antibiotics, analgesics), and distribution channel (hospital pharmacies, retail pharmacies, drug stores and online pharmacies) across seven regions.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15446

Key Market Segments Covered in Multiple Unit Pellet Systems Industry Research

By Formulation:

Extended Release Dosage Form
Delayed Release Dosage Form
Delayed Release Orodispersible Dosage Form
Others

By Dosage Form:

Tablets
Capsules
Sachets
Others

By Drug Class:

Anti-Hypertensive
Proton Pump Inhibitors
Antibiotics
Analgesics
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Development Trends

4. Key Inclusions

4.1. Product Adoption/ Usage Analysis

4.2. Key Promotional Strategies, by Manufacturers

4.3. Technology Assessment

4.4. Regulatory Landscape

4.5. Reimbursement Scenario

4.6. PESTLE Analysis

4.7. Porters Analysis

4.8. Value Chain Analysis

Get detailed TOC @ https://www .futuremarketinsights.com/toc/rep-gb-15446

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

https://marketresearchblog.org/2022/08/u-s-digital-ovulation-test-kits-market-generating-a-revenue-of-us-95-1-million-by-2031-4/

https://marketresearchblog.org/2022/08/orthopedic-braces-and-support-market-growth-projection-to-6-9-cagr-through-2024-3/

https://marketresearchblog.org/2022/08/compression-therapy-market-to-reach-us-4-59-billion-by-2030-4/

https://marketresearchblog.org/2022/08/enteral-feeding-devices-market-is-projected-to-progress-at-a-cagr-of-4-7-to-reach-us-3-77-bn-by-2030-2/

https://marketresearchblog.org/2022/08/prescription-delivery-services-market-to-reach-us-434-3-million-by-2030-end-4/
About FMI:

Humeral Implants Market is likely to be valued at US$ 963.8 Million in 2022

[300 Pages Report] The Humeral implants designs have changed significantly as a result of improved understanding of prosthetic biomechanics and proximal humeral anatomy. The primary goal of humeral implant design includes the replication of the articular anatomy to restore physiologic soft-tissue tension and to avoid complications such as periprosthetic fracture, aseptic loosening, and proximal humeral bone loss and to provide early implant stability and long-term bony fixation. Trauma is the main reason for humerus fractures.

The humerus is mostly fractured due to fall or motor vehicle crash. Physical rehabilitation is also an important part of recovery to regain the use of the upper arm and shoulder. Humerus fractures are of different types depending on the name of the area of bone that is broken. These are proximal humerus fractures, mid-shaft fractures, and distal humerus fractures. If the bone is moved out of the position, surgery is recommended. Surgery is used to readjust the bone and secure them in a position with surgical hardware, such as pins, plates, wires, and screws.For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6002

For severe proximal humerus fractures, shoulder replacement surgery is done to remove the injured bone and insert an artificial implant. Both non-cemented and cemented fixation are used, as both techniques have different advantages and disadvantages. Humeral implants have grown from monoblock to modular implants, from diaphyseal to metaphyseal fixation, from press-fit to ingrowth non-cemented designs and from fixed to variable implants.

Humeral Implants Market: Drivers and Restraints

The global humeral implants market is anticipated to register a significant CAGR over a forecast period. The rise in geriatric population and increased number of accidents is anticipated to boost the demand for the humeral implants and drives the global humeral implants market.

Changes in lifestyle such as lack of exercise and increased prevalence of obesity in global population are attributing to the weakening of bones, fuelling humeral implants market growth. Increase in the adoption of advanced technologies and ongoing technological advancements also anticipated to drives the global humeral implants market.

However, high complication rates such as aseptic loosening and need of humeral revision associated with the procedures may hamper the demand for the humeral implants and restrain the growth of the global humeral implants market. Additionally, stringent FDA policies for the approval of implants will restrain the growth of humeral implants market.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-6002

Humeral Implants Market: Regional Outlook

On the basis of regional presence, the global humeral implants market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa. Currently, North America is contributing the leading shares to the global systems humeral implants market in terms of value and anticipated to register a significant CAGR over a forecast period.

APEJ is also contributing moderate shares to the market due to the newly developed products and growing incidence of injuries is expected to show a robust growth to the global humeral implants market. Europe is the most lucrative market for the humeral implants market. MEA is at a nascent stage to the global humeral implants market and anticipated to register a decent growth to the market over a forecast period. Overall, the global humeral implants market is expected to show significant growth over a forecast period.

Humeral Implants Market: Key Players

Some of the major market players in humeral implants market globally include B. Braun Ireland, Arthrex, Inc., Exactech, Inc., medartis, Zimmer Biomet, Smith & Nephew plc., Stryker, Wright Medical Group, DePuy Synthes and others. These companies are highly focused on the development of advanced humeral implants further contributing to the growth of humeral implants market globally.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-6002

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Humeral Implants Market: Segmentation

The global humeral implants market is segmented on the basis of product type and end user:

On the basis of product type, the global humeral implants market is segmented into:

Proximal humerous implants
Humeral shaft implants
Distal humerous implants

On the basis of end user, the global humeral implants market is segmented into:

Hospitals
Ambulatory surgical centers
Clinics

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

About FMI:

Bronchopulmonary Dysplasia Treatment Market is projected to accumulate US$ 661.7 Million by registering a CAGR of 6.1% from 2022-2032

[308 Pages Report] The global bronchopulmonary dysplasia treatment market is expected to be worth US$ 346 million in 2022 and US$ 661.7 million by 2032, growing at a CAGR of 6.1% during the forecast period. The increasing cases of bronchopulmonary dysplasia, as well as the rise in premature births, can be attributed to the growth of the bronchopulmonary dysplasia treatment market. In the historical period 2016-2021, the market for bronchopulmonary dysplasia treatment grew at a CAGR of 5.9%.

Bronchopulmonary Dysplasia Treatment Market: Overview

Companies are focusing on the development of novel treatment option for bronchopulmonary dysplasia for the faster action and quick relief than the conventional dosage forms. For instance, Airway Therapeutics, LLC developed AT-100, a recombinant form of human surfactant protein, for maintaining healthy lung function in infants with bronchopulmonary dysplasia. On the other hand, research are developing stem cell therapy for novel therapeutic modality for attenuating BPD severity. Moreover, the first phase I clinical trial of stem cell transplantation for bronchopulmonary dysplasia is successfully conducted by proving its safety and feasibility in the preterm infants.

Bronchopulmonary Dysplasia Treatment Market: Drivers and Restraints

According to the Airway estimates, in Europe and the U.S. up to 160,000 infants are at highest risk for the development of BPD collectively, each year. Similarly, With 73.6 million live births in Asia and a preterm rate <32 weeks of approximately 2.2%. Government initiatives, favorable reimbursement policies, increasing prevalence of bronchopulmonary dysplasia, and raise in cases of premature births leading to bronchopulmonary dysplasia are boosting the growth of bronchopulmonary dysplasia treatment market over the forecast period. Growing research and development activities by pharmaceutical companies to develop innovative treatment option for bronchopulmonary dysplasia would boost the market in near future.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-4389

Bronchopulmonary dysplasia is a chronic respiratory disease, which is most commonly occurs in premature infants and who received supplemental oxygen or mechanical ventilation. It is also called as respiratory distress syndrome. In addition, bronchopulmonary dysplasia can also occur in infants who experience abnormal lung development or had pre-birth antenatal infection. Most of the infants recover from bronchopulmonary dysplasia, however, some of those have continued lung function and structure abnormalities during adolescence and adulthood. This condition can cause serious complications during infancy and might requires hospitalization and intensive medical care, during the first 2 years after birth. The signs and symptoms for BPS includes shallow, rapid breathing, chronic cough, shortness of breath, flaring of nostrils while breathing, and discoloration of skin owing to low blood oxygen levels. Many cases of BPD are associated with excess oxygen levels and mechanical ventilation. The disease can cause from other conditions such as antenatal infection, maternal complications, preeclampsia, and inflammation of the fetal membranes, that affects the development of the lungs.

Bronchopulmonary Dysplasia Treatment Market: Key Players

Some of the players in global bronchopulmonary dysplasia treatment market include Airway Therapeutics LLC, Chiesi Farmaceutici SpA, Insmed Incorporated, MediPost Co., Ltd., Meridigen Biotech Co., Ltd, Syntrix Biosystems, Inc., Therabron Therapeutics, In,

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4389

Bronchopulmonary Dysplasia Treatment Market: Segmentation

The global bronchopulmonary dysplasia treatment market is classified on the basis of drug class, therapy type end user, and geography.

Based on drug type, the global bronchopulmonary dysplasia treatment market is segmented into the following:

Bronchodilators
Diuretics
Antibiotics
Steroids
Immunomodulators
Surfactant Homeostasis

Based on therapy type, the global bronchopulmonary dysplasia treatment market is segmented into the following:

Nitric Oxide Therapy
Protein replacement therapy
Stem Cell Therapy
Supplemental Oxygen

Based on end user, the global bronchopulmonary dysplasia treatment market is segmented into the following:

Hospitals
Nursing Homes
Critical Care Centers

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/4389

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

https://www.fmiblog.com/2022/08/22/soft-tissue-repair-market-is-projected-to-reach-nearly-us-15500-million-by-2022-end-2/

https://www.fmiblog.com/2022/08/22/sleep-aid-devices-market-is-projected-to-surpass-us-133211-98-million-by-2032/

https://www.fmiblog.com/2022/08/22/animal-model-market-is-projected-to-be-valued-at-us-1-7-billion-in-2022-2/

https://www.fmiblog.com/2022/08/22/dermal-fillers-market-current-trends-and-future-growth-estimations-outlook-to-2031-3/

https://www.fmiblog.com/2022/08/22/pipette-tips-market-is-projected-to-surpass-usd-1-47-billion-by-2032-2/

About FMI:

Back Therapy Kits Market to expand at a 4.6% value CAGR during forecast period by 2032

Back therapy kits are the home used a medical device which is used for the pain management especially of the lower back. Back therapy kits is placed on the lower back of the human body and it is fixed with the help of the strap. Back therapy kits use TENS technology to pass on vibration to the body for the pain management.

The vibration from the back therapy kits releases the muscles strain which is results the reduction in the back pain. The back pain patients are prescribed to take 15-20 session everyday with back therapy kits to manage their pain. Back therapy kits are also used by the sportsperson to relax their lower.

To reduce the lower back pain due to muscle strain from exercise, back therapy kits are a very useful medical device. Back therapy kits are generally used at home and also at the rehabilitation centers.

Back Therapy Kits Market: Drivers and Restraints

The rising prevalence of lower back is the primary factor driving the growth of back therapy kits market over the forecast period. The prevalence of lower back is rising exponentially due change in lifestyle of people which is ultimately responsible for the growth of back therapy kits market over the next decade.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8416

Also, the attention of the majority of people toward their personal health increases and not doing exercise on a daily basis has also increased the chances of lower back pain, resulting in the rising demand of back therapy kits.

The increasing number of injuries to sportspersons and rising adoption of back therapy kits at a rehabilitation center also fueling the growth of back therapy kits market. The high cost of back therapy kits which could not be afforded by the majority of people in the under developing economies may deter the growth of the back therapy kits market to some extent.

Also, the lack of awareness among the people about the positive results of back therapy kits may also hamper the growth of back therapy kits market.

Back Therapy Kits Market: Market Overview

The change in lifestyle which increases the incidences of lower back pain is responsible for the exponential growth of back therapy kits market over the forecast period. Lower back pain has become common health problem throughout the globe which is the major cause of disability and affecting the day today life of people.

According to the World Health Organization, the prevalence of back pain range between 15-45% in the adult population worldwide. World Health Organization also estimates that the incidence of lower back pain is very much higher in population between the ages between 25-55. By product type, strapped back therapy kits is expected to gain major market share in back therapy kits market due to its high acceptability in the market.

Strapless back therapy kits are the advance version of back therapy kits, hence it expected to gain more traction in the market over the forecast period. Among all end user back therapy kits are most widely used homecare settings which is then followed by rehabilitation centers.

Back Therapy Kits Market: Regional Overview

On the basis of geography, Back Therapy Kits market is classified into eight key regions viz. North America, Latin America, Europe, APECJ, China, Japan, Middle East and Africa. North America is expected to dominate the global Back Therapy Kits market due to high healthcare spending in U.S. and Canada. After North America Back Therapy Kits market is then followed by Europe due to rising incidences of back pain in this region.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-8416

APEC and China is the fastest growing region for global Back Therapy Kits market owing to the huge geriatric population this region. Middle East and Africa and Latin America region is expected to show delayed growth for Back Therapy Kits market due to lack of awareness among the people about the advance therapies for available in the market for pain management.

Back Therapy Kits Market: Key Players

Some of the key players found across the value chain of Back Therapy Kits market are Sanofi S.A., Bayer AG, Hocomo, Polar Products Inc., Tynor, Brooks Life Sciences, Alliance Spine, Amedica, Captiva Spine, Globus Medical and others.

The report covers exhaust analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Indication
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific excluding China & Japan (India, ASEAN, Australia & New Zealand)
China
Japan
Middle East and Africa (GCC Countries, South. Africa, Northern Africa)

For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/askus/rep-gb-8416

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Back Therapy Kits Market: Segmentation

The global back therapy kits market is classified on the basis of product type, end user, and region.

Based on product type back therapy kits market is segmented into following:

Strapped back therapy kits
Strapless back therapy kits

Based on connectivity back therapy kits market is segmented into following

Wired back therapy kits
Battery operated back therapy kits

Based on end user back therapy kits market is segmented into following:

Hospital
Orthopedic Clinics
Rehabilitation Centers
Long Term Care Centers
Homecare Settings

About FMI:

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Sleep Aid Devices Market is projected to surpass US$ 133211.98 Million by 2032.

Multiple government & non-government societies such as ASAA (American Sleep Apnea Association) and Circadian Sleep Disorder Networks have underpinned the growth of the sleep aid devices market by organizing various sleep cognizance programs pertaining to the importance of sound sleep. As a result, there has been a significant rise in the demand for sleep aid devices for the treatment of sleep-related disorders.

According to a recently published research report by Future Market Insights (FMI), the global sleep aid devices market is projected to be valued at US$ 29,200 Mn by the end of 2026. Increasing stress levels and rise in the sleeping disorders such as sleep deprivation, narcolepsy, restless legs syndrome, sleep apnea, and insomnia have necessitated the need for medical intervention. Among the various options available to healthcare providers and patients, the adoption of sleep aid devices has grown steadily.

Disposable income in the developing economies has been constantly increasing, which has upgraded the lifestyle of people. A sheer demand for advanced and secured sleep aid devices has been witnessed in these markets, on the back of enhanced spending capacity of the consumers. These factors have offered a lucrative growth opportunity to the manufacturers of these devices and as a result, the global sleep aid devices market is predicted to clock an impressive CAGR of over 4% by the end of 2026.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8956

Proclivity for Smoke and Alcohol Drives the Sales of Sleep Aid Devices at the Global Level

Increasing geriatric population and sleep disorders associated in this demography have created a robust demand for the sleep aid devices. Furthermore, a rise in the sedentary lifestyle and the comorbidities such as heart disease, obesity, stroke, type 2 diabetes, and atherosclerosis have resulted in the widespread utilization of sleep aid devices. Proclivity of adults for smoking, drug abuse, and alcohol at a global level have been a driving factor for the growth of the sleep aid devices market.

North America to Lead the Global Sleep Aid Devices Market, Europe Second Largest Market

As per the insights extracted from the descriptive study based on the sleep aid devices market, the market of Europe and North America reigns supreme on the back of reimbursement provided by the government. Moreover, a rise in the per capita medical expenditure of the consumers hailing from these regions has alongside contributed to the growth of the global sleep aid devices market.

As compared to the developed economies in North America and Europe, the sleep aid devices market in the emerging economies will witness an impressive rate of growth, on account of supportive government policies and ongoing development in the healthcare sector.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8956

Comprehensive Look at the Competitive Landscape of the Global Sleep Aid Devices Market

Key information obtained from the market study includes an analytical view of the key players transforming the current sleep aid devices market scenario. This descriptive report highlights companies such as

ResMed Inc.
Sleep Number Corporation
Koninklijke Philips N.V.
Responsive Surface Technology LLC
Simmons Bedding Company LLC
Eight Sleep Inc.
Electromedical Products International, Inc.
Ebb Therapeutics
Sleepace Inc.
Kingsdown, Inc.
Drive DeVilbiss Healthcare LLC
SleepMed Inc.
Cadwell Laboratories Inc.
Teva Pharmaceutical Industries Ltd.
Drive Medical Ltd.

Key companies such as Tempur Sealy International, Simmons Bedding Company LLC, Sleep Number Corporation, Dreams, ResMed, and Koninklijke Philips N.V. procure a major share in the sleep aid devices market. Aforementioned manufacturers are endeavoring into developing new products for diversifying their portfolio in the sleep aid devices market. Key manufacturers of sleep aid devices market are collaborating with retailers, distributors, and local wholesalers, in order to expand their operations

Domestic companies are competing depending on their channel management and pricing of the sleep aid devices. On the other hand, key players in the sleep aid devices market are concentrating their efforts on devising effective marketing strategies in order to increase the penetration of their products.

Table Of Content

Executive Summary
- Market Overview
- Market Analysis
- PMR Analysis and Recommendations
- Wheel of Fortune
Market Introduction
Market Definition
Market Taxonomy

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8956

Sleep Aid Devices Market Opportunity Analysis

Macro-Economic Factors
Opportunity Analysis

Market Background

Value Chain Analysis
Market Dynamics
Drivers
Supply Side Drivers
Demand Side Drivers
Restraints
Key Trends

Global Economic Outlook

1. Gross Domestic Product by Region & Country, 2016 – 2021
2. Medical Devices Sector Outlook

Key Inclusions

1. Disease Epidemiology, Statistics
2. White Space Opportunities Narcolepsy and Obstructive Sleep Apnea Diseases
3. Technology Assessment

6.4. Regulatory Guidelines

6.5. Pricing Analysis

North America Sleep Aid Devices Market Analysis 2013–2017 and Forecast 2018–2026

Introduction
Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
Canada
Market Size (US$ Mn) Forecast By Country, 2018–2026
Historical Market Value (US$ Mn) and Volume Units Trend Analysis By Product Type, 2013 – 2017

About FMI:

Unilateral Biportal Endoscopy Market is projected to expand at a CAGR of 6.5% from 2022 to 2032

The global Unilateral Biportal Endoscopy market is estimated at USD 750 Million in 2021 and is projected to procure USD 798 Million by 2022. The market is anticipated to garner USD 1500 Million by 2032 while recording a CAGR of 6.5% during the forecast period from 2022 to 2032. Expansion of the market can be attributed to the increasing rate of the geriatric population and hefty investments in the medical infrastructure across developing countries.

Moreover, the growing adoption of reusable segment Unilateral Biportal Endoscopy Aviation is gaining the highest traction due to its recoverability rate and categorization based on exposure to infection risk. The growing investment in the healthcare sector backed by the favorable policies by U.S and Canadian hospitals is likely to boost the demand for the aforementioned market in the forthcoming period.On the contrary, owing to the high cost and lack of skilled endoscopy professionals are the prominent aspects restraining the market expansion of the global unilateral biportal endoscopy market.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14997

Key Takeaways from the Market Study

Unilateral Biportal Endoscopy for Decompression application segment captures the largest share of more than 40% across the globe, documenting a CAGR of 7% throughout the forecast period.
Reusable type segment to expand at a CAGR of 6.7% during the forecast period
Hospitals segment is likely to capture the largest market share of more than 48%
The North American market is expected to secure USD 720 Million while expanding at a CAGR of 7%
APAC to record a CAGR of 6.5% during the forecast period

“Increasing prevalence of chronic diseases like cancer and upward trend of adopting less invasive procedure is propelling the demand for the Unilateral Biportal Endoscopy across the world.” says an analyst at Future Market Insights

Competitive Landscape

Key players in the global Unilateral Biportal Endoscopy market include Endovision Co. Ltd., Karl Storz, Smith & Nephew, Stryker Corporation, CONMED Corporation, Maxer Endoscopy GmbH, Joimax GmbH, Richard Wolf, Jiangsu Bonss Medical Technology Co. Ltd., Kinetix Lifesciences

Some of the recent key developments among the players are:

In May 2022, Boston Scientific Corporation announced the worldwide commercial availability of its SpyGlass™ Direct Visualization System for single-operator duodenoscope assisted cholangiopancreatoscopy (SODAC) or visual examination of the bile ducts.
In Jan 2022, Stryker announced completed the acquisition of all of the issued and outstanding shares of common stock of Vocera Communications, Inc. for $79.25 per share, or a total equity value of approximately $2.97 billion and a total enterprise value of approximately $3.09 billion.
In May 2022, DLA Piperadvised CONMED Corporation in its agreement to acquire privately-held In2Bones Global, Inc. (In2Bones), on a cash-free, debt-free basis, for cash consideration of US$145 million at closing. The deal also includes an additional US$110 million in growth-based earnout payments over four years

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-14997

More Valuable Insights Available

FMI, in its new offering, presents an unbiased analysis of the global Unilateral Biportal Endoscopy, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights by Product Outlook (Reusable, Single-use), by Application (Decompression, Lumbar Central Canal Stenosis, Degenerative Lumbar Canal Stenosis, Lumbar Spinal Stenosis, Deherniation, Spinal Stabilization, Others), by End-user (Hospitals, Ambulatory Surgery Centers/Clinics, Other end-users) & Region (North America, Latin America, Europe, East Asia, South Asia & Oceania, and the Middle East & Africa).

Key Segments Covered in the Unilateral Biportal Endoscopy Industry Survey

Unilateral Biportal Endoscopy by Product Outlook:

Reusable Unilateral Biportal Endoscopy
Single-use Unilateral Biportal Endoscopy

Unilateral Biportal Endoscopy by Application:

Unilateral Biportal Endoscopy for Decompression
Unilateral Biportal Endoscopy for Lumbar Central Canal Stenosis
Unilateral Biportal Endoscopy for Degenerative Lumbar Canal Stenosis
Unilateral Biportal Endoscopy for Lumbar Spinal Stenosis
Unilateral Biportal Endoscopy for Deherniation
Unilateral Biportal Endoscopy for Spinal Stabilization
Others

Unilateral Biportal Endoscopy by End-user:

Unilateral Biportal Endoscopy in Hospitals
Unilateral Biportal Endoscopy in Ambulatory Surgery Centers/Clinics
Other end-users

Unilateral Biportal Endoscopy by Region:

North America Unilateral Biportal Endoscopy Market
Latin America Unilateral Biportal Endoscopy Market
Europe Unilateral Biportal Endoscopy Market
Asia Pacific Unilateral Biportal Endoscopy Market
The Middle East & Africa Unilateral Biportal Endoscopy Market

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14997

About FMI:

Contact:

Elastography Imaging Market is likely to exhibit the said growth at a CAGR of 11.2% during the forecast period from 2022 to 2032

Elastography is a medical imaging technique used to measure elastic properties and stiffness of the soft tissues. Ultrasound and magnetic resonance imaging are the most common elastography technique used to make stiffness map, determination of several diseases in the body. Elastography imaging is taking place of biopsy as a completely non-invasive technique. Elastography imaging is used for the detection of several cancers such as breast cancer, thyroid cancer, and prostate cancer.

Elastography imaging is majorly used to diagnosis of liver disease. The particular type of elastography imaging is used for the musculoskeletal imaging to determine mechanical properties and state of muscle and tendon. Magnetic resonance elastography imaging technique capable of assessing the stiffness of the brain. Based on the source, elastography imaging classified as static (Strain imaging) or dynamic (Shear wave imaging) techniques. Shear wave imaging includes techniques such as 1D transient elastography, point shear-wave elastography, shear-wave elastography, and MR Elastography.

Elastography Imaging Market: Drivers and Restraints-

Companies are focusing on the launch of new elastography imaging product, which expected to favor the growth of the elastography imaging market. Manufacturers are focusing on clinical trials and FDA approvals for market expansion. In February 2017, FDA approved Phillips ElastQ Imaging capability (shear wave elastography) for imaging of tissue.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9655

The growing number of liver disease such as hepatitis B, liver cancer expected to favour the growth of the elastography imaging market. Elastography imaging devices are gaining popularity over the biopsy process as benefits of non-invasive procedures. Increasing incidence of various cancers expected to favour the demand for the elastography imaging devices. Increasing adoption of minimally invasive procedures favours the growth of the elastography imaging market. Magnetic resonance elastography is gaining high demand for brain tissue imaging as a non-invasive procedure.

Elastography Imaging Market: Overview

Ultrasound elastography imaging is the most commonly performed technique as inexpensive, portable and good diagnostic accuracy. But ultrasound elastography imaging may be unreliable in the patient with narrow intercostal spaces and high obesity. MR elastography imaging offers excellent diagnostic accuracy. MR elastography imaging becomes a reference standard for patients among which liver biopsy is not feasible. Based on application elastography imaging market are segmented into gynecology & obstetrics, cardiology, orthopedic & musculoskeletal, vascular, neurology and general imaging. Hospitals and diagnostic imaging centers are accounted for higher market value share in the elastography imaging market.

Elastography Imaging Market: Region-wise Outlook

North America is the most dominating market for elastography imaging market due to the growing adoption of advanced imaging techniques and early commercialization of devices in the U.S. market. Western Europe expected to contribute the second largest market share in the elastography imaging market. Factors such as growing research projects and growing adoption ultrasound screening favor the growth of the Europe elastography imaging market. Moreover, Asian countries such as India, China, South Korea grow with higher growth rate as improvement in healthcare technologies, government funding for screening and imaging of disease like cancer.

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-9655

Elastography Imaging Market: Key Market Participants

Example of some market players participants in global elastography imaging market find across the value chain are Samsung Medision, GE healthcare, Koninklijke Philips N.V., Siemens Healthineers, Hitachi Ltd., Mindray Medical International Limited, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Landwind Medical, Esaote SpA, SonoScape Medical Corp, SuperSonic Imagine and others.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact:

High flow Ventilators Market to expand at a 10% value CAGR during forecast period by 2032

Ventilators are regarded as a critical life-support device which provides respiratory therapy to the general population. High flow ventilators are respiratory support system which is generally used in the hospitals, ambulatory surgical centers, and other facilities for patients suffering from acute and chronic respiratory failure. Generally, a traditional oxygen therapy is up to 16L/min, whereas high flow ventilators use oxygen therapy up to 60L/min. This reduces the need for noninvasive ventilation and intubation in the target population. High flow ventilators usually deliver the oxygen therapy using a blender connected to a wall outlet, heated tubing, a humidifier, and nasal cannula.

Humidified constant flow in high flow ventilators improves gas exchange and reduces work of breathing. High flow ventilators are majorly used in COPD, end-stage cancer, bronchiectasis, and do-not-intubate patients. High flow ventilators eliminate most of the anatomic dead space and create a reservoir with high FiO2 in the nasal cavity.

High Flow Ventilators Market: Drivers and Restraints

Increasing prevalence and incidence of respiratory disorders and chronic obstructive pulmonary disease (COPD) are considered as the major factors responsible for driving the growth of the global high flow ventilators market globally. Furthermore, the rising number of surgeries increases the demand for cost saving and high-end technologies in critical care which drives the growth of the global high flow ventilators market.

Increasing the relevance of hospitals, and medical emergency services increase the demand for high flow ventilators. However, stringent regulatory approvals and budget constraints faced by the manufacturers are expected to hamper the growth of the global high flow ventilators market.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8414

High Flow Ventilators Market: Overview

High flow ventilators deliver a high flow oxygen blend through a nasal cannula, providing an alternative to other forms of ventilation. High flow ventilators market is expected to grow at a considerable growth rate due to the growing prevalence of COPD disorders. High flow ventilators are majorly used for treating hypoxemic respiratory failure. Based on the end user, the market is divided into ambulatory surgical centres, hospitals, long-term care centers, specialty clinics, and others. Amongst them, hospitals are expected to hold maximum market share due to the more accessibility.

High Flow Ventilators Market: Regional Outlook

On the basis of geography, the global high flow ventilators market is segmented into eight key regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding China and Japan, China, Japan, and Middle East & Africa.

North America high flow ventilators market is expected to hold maximum market share in the global high flow ventilators market due to the strong presence of key manufacturers in the region. Western Europe is anticipated to hold the second highest market share in the global market.

Asia Pacific region is expected to grow with the maximum growth rate over the forecast period. However, the High Flow Ventilators Market in the low middle-income region like Eastern Europe, Latin America, and the Middle East and Africa is anticipated to show a sluggish growth over the forecast period.

High Flow Ventilators Market: Key Players

Examples of some of the key players in the global high flow ventilators market are ResMed, Hamilton Medical, HERSILL, S.L., Tecno-Gaz S.p.A., Essex Industries, Inc., and others. Companies are actively indulging into collaboration by acquiring international and domestic players in order to expand their product portfolios and distribution channels in the emerging market.

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-8414

Technological advancements is another one of the major factors for manufacturers to improve technologies. The adoption of various strategies by the high flow ventilators market players helps the high flow ventilators market to grow at a significant growth rate.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain

The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
China
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-8414

High Flow Ventilators Market: Segmentation

The global high flow ventilators market is segmented by modality type, end user and region:

Based on Modality Type, the global high flow ventilators market is segmented into:

Portable High Flow Ventilators
Trolley Mounted High Flow Ventilators

Based on End User, the global high flow ventilators market is segmented into:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Long Term Care Centers
Others

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

About FMI:

Contact:

Soft Tissue Repair Market is projected to reach nearly US$ 15,500 Million by 2022-end.

A new report by Future Market Insights (FMI) anticipates the global soft tissue repair market to exhibit a steady 5.5% CAGR throughout the forecast period (2017-2022). The global market for soft tissue repair is expected to account for over US$ 15,000 Mn revenues by 2022-end.

Advancements in Products such as Bioabsorbable Soft Tissue Screws to Propel Growth of the Market

A number of technological advancements and innovations have been observed in orthopedic connective tissue repair procedures. Novel advances, for instance – the innovative surgical techniques, are being made in the procedures associated with anterior cruciate ligament (ACL) reconstruction, in a bid to make the process more effective. Global leaders, including Zimmer Biomet and NORAKER, have been developing new bioabsorbable soft tissue screws over the past few years. Leading market players have also been focusing on development of the mesh with biological products, which would act as a replacement for human allograft. An example of this is development of EZ Derm by MoInlycke Health Care, utilized as dressing for wounds using wires and pins independently, or together, with various other internal fixation devices. These devices are utilized for surgeries pertaining to hip replacement and spine.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4931

People across the globe are becoming aware of development, promotion, and commercialization of the advanced platelet-rich plasma devices, used for musculoskeletal disorders. In addition, there is a surge in awareness about skeletally immature patients to have a high risk of tear in the connective tissue and ligaments. These factors might positively impact global demand for soft tissue repair in the near future.

Sports-related Injuries- A Major Factor Driving the Market Growth

A major factor affecting demand for soft tissue repair is injuries related to sports. Athletes usually suffer from ACL tear during the game, or while performing other physical activities. Moreover, increasing aging population is also expected to play an imperative role in growth of the market. With aging, substantial changes are observed in skeletal and neuromuscular systems, which in turn leads towards ACL tear, weak ligaments and arthritis. Prevalence of obesity in geriatric population is directly increasing risk of degenerative bone diseases, such as osteoporosis and osteoarthritis. The aforementioned factors are further expected to increase demand for soft tissue repair procedures.

In contrast, high prices associated with soft tissue repair procedures, lack of awareness in population across underdeveloped and remote regions, and unfavorable reimbursement policies are factors which will impede demand for soft tissue repair procedures in the near future.

APEJ to Witness a Significant Expansion in the Market

The soft tissue repair market in Asia-Pacific excluding Japan (APEJ) is expected to witness a significant growth, with revenues poised to surpass US$ 3,000 Mn by 2022-end. Growth of the market in APEJ can be primarily attributed to increasing purchasing power of population, and rising prevalence of musculoskeletal disorders in countries such as India and China. In addition, North America is expected to remain the most attractive market for soft tissue repair, owing to the hike in healthcare expenditure in this region.

Based on product, sales of laparoscopic instruments, and synthetic mesh are expected to collectively account for over one-third revenue share of the market during the forecast period. Sales of synthetic mesh and laparoscopic instruments will register similar CAGRs through 2022.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4931

Orthopedic Application of Soft Tissue repair to Account for Largest Revenue Share

Orthopedic application of soft tissue repair are expected to account for the largest revenue share of the market during 2017 to 2022, followed by skin repair application. In addition, revenues from orthopedic and skin repair application of soft tissue repair are expected to collectively account for over US$ 7,000 Mn by 2022-end.

Accounting for around two-third revenue share of the market, hospitals are expected to remain the most lucrative end-users in the global market for soft tissue repair. Revenues from hospitals in the market are expected to reach approximately US$ 10,000 Mn by 2022-end.

Key players profiled by the FMI’s report, who are actively operating in the global soft tissue repair market, include

Wright Medical Group N.V.
Integra LifeScience Corporation
Medtronic Plc.
CONMED Corporation
C. R. Bard Inc.
Braun Melsungen AG
Smith & Nephew
DePuy Synthes
Stryker Corporation
Zimmer Biomet Holdings Inc.
Arthrex Inc.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-4931

Market TaxonomyIn one of its chapters, the report provides an in-depth analysis of the market segmentation, which is based on product, application, end-user, and region. The report offers insights on every market segment and its sub-segments in terms of absolute $ opportunity, Y-o-Y growth, market attractive index, market size, and BPS analysis.

Product

Allograft
Xenograft
Synthetic Mesh
Interference Screws
Suture Anchors
Laparoscopic Instruments
Other Fixation Devices

End User

Hospitals
Clinics
ASCs

Application

Breast Reconstruction Repair
Dental
Dural Repair
Hernia Repair
Orthopedic
Skin Repair
Vaginal Sling Procedures
Others

About FMI: